E
KIN

Ergoteles’s Kindred Biosciences, Inc. KIN Stock Holding History

Ergoteles’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-441,884
Closed -$4.05M – 1864
2021
Q2 		$4.05M Buy
+441,884
New +$2.57M 0.09% 256

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Ergoteles's KIN Position: Q3 2021 in Review

Ergoteles sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 441,884 shares — an estimated $4.05M sold.

Ergoteles first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $4.05M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • Ergoteles reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Ergoteles sold 441,884 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $4.05M.
  • Ergoteles first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
  • Ergoteles's Kindred Biosciences, Inc. position peaked at $4.05M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.